Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CA mutation + PTEN deletion
i
Other names:
PIK3CA, Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha, Phosphoinositide-3-kinase, catalytic, alpha polypeptide, Serine/threonine protein kinase PIK3CA, PtdIns-3-kinase subunit P110-alpha, PI3K-alpha, Phosphatidylinositol-4,5-bisphosphate 3-kinase 110 KDa catalytic subunit alpha, Phosphatidylinositol 3-kinase, Catalytic, 110-KD, alpha, PI3-kinase P110 subunit alpha, PI3-kinase subunit alpha, PtdIns-3-kinase subunit alpha, PI3Kalpha, P110alpha, PI3K, PTEN, Phosphatase and
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5290
;
5728
Related biomarkers:
Expression
Mutation
CNA
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CA mutation + PTEN deletion
Lung Adenocarcinoma
PIK3CA mutation + PTEN deletion
Lung Adenocarcinoma
gefitinib
Sensitive: C3 – Early Trials
gefitinib
Sensitive
:
C3
gefitinib
Sensitive: C3 – Early Trials
gefitinib
Sensitive
:
C3
PIK3CA mutation + PTEN deletion
Lung Adenocarcinoma
PIK3CA mutation + PTEN deletion
Lung Adenocarcinoma
osimertinib
Sensitive: C3 – Early Trials
osimertinib
Sensitive
:
C3
osimertinib
Sensitive: C3 – Early Trials
osimertinib
Sensitive
:
C3
PIK3CA mutation + PTEN deletion
Solid Tumor
PIK3CA mutation + PTEN deletion
Solid Tumor
copanlisib
Sensitive: C3 – Early Trials
copanlisib
Sensitive
:
C3
copanlisib
Sensitive: C3 – Early Trials
copanlisib
Sensitive
:
C3
PIK3CA mutation + PTEN deletion
Lung Non-Small Cell Squamous Cancer
PIK3CA mutation + PTEN deletion
Lung Non-Small Cell Squamous Cancer
osimertinib
Sensitive: C4 – Case Studies
osimertinib
Sensitive
:
C4
osimertinib
Sensitive: C4 – Case Studies
osimertinib
Sensitive
:
C4
PIK3CA mutation + PTEN deletion
Breast Cancer
PIK3CA mutation + PTEN deletion
Breast Cancer
GDC-0941
Sensitive: D – Preclinical
GDC-0941
Sensitive
:
D
GDC-0941
Sensitive: D – Preclinical
GDC-0941
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.